Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Patent Publication Number 20220370441
US 20220370441 A1Publication DateNov 24, 2022
Original AssigneeAbbvie Inc.
Roche
Roche
Current AssigneeAbbvie Inc.
Roche
Roche
Inventor/ApplicantsChristian Klein
Wayne John Fairbrother
Sari L. Heitner Enschede
Andrew W. Roberts
Deepak Sampath
John F. Seymour
Rod A. Humerickhouse
Wayne John Fairbrother
Sari L. Heitner Enschede
Andrew W. Roberts
Deepak Sampath
John F. Seymour
Rod A. Humerickhouse
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.